Preclinical Drug Development: 2nd Edition (Hardback) book cover

Preclinical Drug Development

2nd Edition

Edited by Mark Rogge, David R. Taft

CRC Press

376 pages | 16 Color Illus. | 58 B/W Illus.

Purchasing Options:$ = USD
Hardback: 9781420084726
pub: 2009-09-25
SAVE ~$42.00
Currently out of stock
$210.00
$168.00
x
eBook (VitalSource) : 9780429142192
pub: 2016-04-19
from $105.00


FREE Standard Shipping!

Description

Preclinical Drug Development, Second Edition discusses the broad and complicated realm of preclinical drug development. Topics range from assessment of pharmacology and toxicology to industry trends and regulatory expectations to requirements that support clinical trials.

Highlights of the Second Edition include:

  • Pharmacokinetics
  • Modeling and simulation
  • Formulation and routes of administration
  • Toxicity evaluations
  • The assessment of drug absorption and metabolism
  • Interspecies scaling
  • Lead molecule selection and optimization via profiling
  • Screening using in silico and in vitro toxicity evaluations

The book also includes case studies on preclinical pharmacokinetic-pharmacodynamic modeling and simulation in drug development, a review of ICH preclinical guidelines, and experimental methods used to study membrane drug transport and metabolism. This guide is a fundamental resource for medicinal chemists, biologists, and other specialists in the drug development sciences.

Table of Contents

The Scope of Preclinical Drug Development: An Introduction and Framework; Mark C. Rogge

Lead Molecule Selection: Pharmaceutical Profiling and Toxicity Assessments; P. L. Bullock

Interspecies Differences in Physiology and Pharmacology: Extrapolating Preclinical

Data to Human Populations; M. N. Martinez

Pharmacokinetics/ADME of Small Molecules; A. D. Ajavon and David R. Taft

Pharmacokinetics/ADME of Large Molecules; R. Braeckman

Preclinical Pharmacokinetic–Pharmacodynamic Modeling and Simulation in Drug Development; P. L. Bonate and P. Vicini

Formulation and Production Strategies for Enhancing Bioavailability of Poorly Absorbed Drugs; A. B. Watts and R. O. Williams III

Transporters Involved in Drug Disposition, Toxicity, and Efficacy; C. Q. Xia and G. T. Miwa

Toxicity Evaluations, ICH Guidelines, and Current Practice; J. L. Larson

Application of Pathology in Safety Assessment; Robert A. Ettlin and David E. Prentice

Utilizing the Preclinical Database to Support Clinical Drug Development; H. Lee

Index

About the Series

Drugs and the Pharmaceutical Sciences

Learn more…

Subject Categories

BISAC Subject Codes/Headings:
MED071000
MEDICAL / Pharmacology
SCI013000
SCIENCE / Chemistry / General